Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 drug interaction study with simvastatin and rosuvastatin
NCT02675309Phase 1Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Feb 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of elismetrep, sponsored by Mitsubishi Tanabe Pharma. Primary endpoints: Area Under the Plasma Concentration-Time Curve at 72 hours and Maximum Plasma Concentration at 72 hours. Started Feb 2016; status: completed.
02
Drugs
elismetrep
Beyond the preview
Go deeper on NCT02675309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675309.